Understanding how alterations in growth control pathways are translated into changes in the cell cycle regulatory machinery is a major challenge for understanding the development of human cancers. The ability of both tumor suppressor proteins, p53 and BRCA1, to induce the expression of p21 WAF1/Cip1 in combination with the inhibitory activity of p21 WAF1/Cip1 against cyclindependent kinases suggests that the regulation of p21 WAF1/Cip1 expression is an important aspect of mammalian cell cycle growth control. To elucidate the role of serine/threonine protein phosphatase type 5 (PP5) in processes regulating cell cycle progression, we developed antisense oligodeoxynucleotides targeted against PP5 (e.g. ISIS 15534) that specifically inhibit PP5 gene expression. Employing ISIS 15534, we demonstrate that the specific inhibition of PP5 gene expression has a marked antiproliferative effect on cells, characterized by induction of p21 WAF1/Cip1 and the subsequent arrest of cell growth. Investigations into the mechanisms leading to growth arrest reveal that, in the absence of PP5, the expression of p21 WAF1/Cip1 is induced in p53-competent A549 cells but not in p53 protein-deficient T-24 cells. Employing a stable cell line derived from p53-deficient human fibroblast that contains tetracycline-regulated transactivator and operator plasmids to control the expression of wild-type p53 (TR9-7 cells), we then show that the induction of p21 WAF1/Cip1 , which occurs in response to the inhibition of PP5 expression, requires the p53 protein. Additional studies indicate that PP5 acts upstream of p53, influencing both the phosphorylation state and the ability of p53 to bind DNA, without causing an increase in p53 gene transcription. Together these studies suggest that PP5 is a regulatory component of a signaling pathway that affords replicating cells G 1 checkpoint growth control and that it is the regulation of PP5 that, in turn, controls p53-mediated expression of p21 WAF1/Cip1 and growth arrest in this pathway. In addition, since the inhibition of PP5 gene expression has marked antiproliferative activity and the overexpression of p21 WAF1/Cip1 blocks the growth of tumor cells, these studies suggest that compounds that inhibit of PP5 gene expression may be useful in the treatment of human cancers.The reversible phosphorylation of serine and threonine residues on proteins is a mechanism utilized by eukaryotic cells to regulate the biological activity of many enzymes, and phosphorylation influences cellular events as diverse as metabolism, signal transduction, and cell cycle progression. Although the kinases involved in these processes are well recognized, the critical contribution of serine/threonine protein phosphatases (PPases) 1 has only been appreciated more recently (1, 2). Traditionally, mammalian PPases have been grouped into four subtypes (PP1, PP2A, PP2B, and PP2C) based on 1) their biochemical characteristics, 2) their sensitivities to specific inhibitors, and 3) a limited amount of substrate specificity that can be demonst...